Tag: monoclonal antibodies
Global Cancer Immunotherapy market to reach US$ 412.8 billion by 2034:...
With a projected CAGR of 10%, the cancer immunotherapy market is poised for significant growth, fueled by advancements in treatment technologies
EMA approves Biocon Biologics’ new mAbs facility in India
European Medicines Agency also renews GMP certifications for Biocon's manufacturing sites in India and Malaysia, enhancing global biosimilars supply
Avantor completes acquisition of Masterflex®
The acquisition strengthens Avantor's offering across all bioproduction platforms including monoclonal antibodies (mAbs), cell and gene therapy
Monoclonal antibodies to dominate global multiple sclerosis drugs market
Dominance of the segment is likely to be attributed to the launch of new monoclonal antibody products for the treatment of multiple sclerosis, including Ofatumumab and Ublituximab, during the forecast period.....................